Galectin Therapeutics
GALT
GALT
49 hedge funds and large institutions have $8.3M invested in Galectin Therapeutics in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
21% less call options, than puts
Call options by funds: $523K | Put options by funds: $659K
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
Holders
49
Holding in Top 10
–
Calls
$523K
Puts
$659K
Top Buyers
| 1 | +$177K | |
| 2 | +$76.7K | |
| 3 | +$61K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$49K |
| 5 |
MML Investors Services
Springfield,
Massachusetts
|
+$24K |
Top Sellers
| 1 | -$112K | |
| 2 | -$102K | |
| 3 | -$70K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$43.6K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$33K |